FP13.03 IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC
Autor: | Herbst, R., De Marinis, F., Giaccone, G., Vergnenegre, A., Barrios, C., Morise, M., Felip, E., Oprean, C., Kim, Y., Andric, Z., Mocci, S., Enquist, I., Komatsubara, K., Mccleland, M., Deng, Y., Kuriki, H., Villalobos, M., Phan, S., Spigel, D., Jassem, J. |
---|---|
Zdroj: | In Journal of Thoracic Oncology March 2021 16(3) Supplement:S224-S225 |
Databáze: | ScienceDirect |
Externí odkaz: |